BioMed Research International
Volume 2016 (2016), Article ID 6437641, 10 pages
http://dx.doi.org/10.1155/2016/6437641

Research Article

Sundarban Honey Confers Protection against Isoproterenol-Induced Myocardial Infarction in Wistar Rats

Rizwana Afroz,1,2 E. M. Tanvir,1,3 Nurul Karim,¹ Md. Sabir Hossain,¹ Nadia Alam,⁴ Siew Hua Gan,⁴ and Md. Ibrahim Khalil1,4

¹Laboratory of Preventive and Integrative Biomedicine, Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh
²Department of Biochemistry, Primeasia University, Banani, Dhaka 1213, Bangladesh
³Department of Biochemistry and Molecular Biology, Gonoshasthaya Samaj Vittik Medical College, Gono University, Mirzanagar, Savar, Dhaka 1344, Bangladesh
⁴Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia

Received 16 March 2016; Revised 18 April 2016; Accepted 3 May 2016

Academic Editor: Tamer Mohamed

Copyright © 2016 Rizwana Afroz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The present study was designed to investigate the cardioprotective effects of Sundarban honey (SH) in rats with isoproterenol- (ISO-) induced myocardial infarction. Adult male Wistar Albino rats were pretreated with Sundarban honey (5 g/kg) daily for a period of 6 weeks. After the treatment period, ISO (85 mg/kg) was subcutaneously injected into the rats at 24 h intervals for 2 days. ISO-induced myocardial damage was indicated by increased serum cardiac specific troponin I levels and cardiac marker enzyme activities including creatine kinase-MB, lactate dehydrogenase, aspartate transaminase, and alanine transaminase. Significant increases in serum total cholesterol, triglycerides, and low-density lipoprotein-cholesterol levels were also observed, along with a reduction in the serum high-density lipoprotein-cholesterol level. In addition to these diagnostic markers, the levels of lipid peroxide products were significantly increased. The activities of antioxidant enzymes such as superoxide dismutase, glutathione peroxidase, and glutathione reductase were significantly decreased in the hearts after ISO-induced myocardial infarction. However, pretreatment of ischemic rats with Sundarban honey brought the biochemical parameters to near normalcy, indicating the protective effect of Sundarban honey against ISO-induced ischemia in rats. Histopathological findings of the heart tissues further confirmed the biochemical findings, indicating that Sundarban honey confers protection against ISO-induced oxidative stress in the myocardium.

1. Introduction

Sundarban honey (SH) a wild multifloral honey produced by Apis dorsata bees is one of the most renowned types of honey from Bangladesh. Sundarban honey is collected from the Sundarban region, the largest single block of tidal halophytic mangrove forest in the world, located in the southern coastal region of Bangladesh. Apis dorsata bees collect the nectar from Sundarban plant species, for example, Khalsi [Aegiceras corniculatum (L.) Blanco], Kakra [Bruguiera gymnorrhiza (L.) Lam], Keora [Sonneratia apetala (B.) Ham], and Goran [Ceriops decandra (G.) Ding Hou] [1]. Investigation on pharmacological benefits of SH revealed that it is one of the most renowned types of honey from Bangladesh and conferred protection against oxidative stress-induced liver and kidney damage [2, 3].

Free radicals and reactive oxygen species have been implicated in many diseases and have a deleterious effect on cardiac function. Various experimental and clinical studies have shown that enormous quantities of reactive oxygen species including superoxide, H₂O₂, and hydroxyl radicals are generated in the failing myocardium [4]. Therefore, therapeutic interventions that utilize antioxidants with free radical scavenging activities have the potential to be used to combat oxidative stress associated with various cardiovascular diseases, including myocardial infarction (MI). MI is a common presentation of ischemic heart disease (IHD), a clinical syndrome arising from sudden and persistent curtailment of the myocardial blood supply and resulting in myocardial necrosis [5, 6]. It is a complex phenomenon affecting the mechanical, electrical, structural, and biochemical properties of the heart [7]. According to the World Health Organization, MI is predicted to be the major cause of death worldwide by the year 2020 [8].

Isoproterenol 4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol hydrochloride (ISO) is a synthetic catecholamine and β-adrenergic agonist documented to produce severe stress in the myocardium and to result in MI if administered in supramaximal doses [9]. In the rat model, ISO produces myocardial necrosis that leads to cardiac dysfunction, increased lipid peroxidation and increased levels of myocardial lipids, and altered cardiac enzyme and antioxidant activities [4]. The proposed mechanisms to explain ISO-induced MI include generation of highly cytotoxic free radicals through the autoxidation of catecholamines [10]. These free radicals may attack polyunsaturated fatty acids (PUFAs) within the membranes, forming peroxyl radicals. The radicals can then attack adjacent fatty acids, causing a chain reaction of lipid peroxidation (LPO). The lipid hydroperoxide end products are harmful and may contribute to increased membrane permeability, leading to the development of cardiomyopathy [10–12]. The pathophysiological and morphological aberrations produced in hearts of the myocardial necrotic rat model are comparable with those that occur in human MI.

In recent years, the prevention of cardiovascular disease (CVD) has been associated with the consumption of fresh fruits, vegetables, or plants rich in natural antioxidants, because of superiority in terms of efficacy and safety when compared with synthetic products [13]. Previous studies on antioxidant potential of honeys revealed that Sundarban honey contains the highest level of phenolics (688.50 mg gallic acid/kg), flavonoids (155.0 mg catechin/kg), ascorbic acid (146.20 mg/kg), and protein (8.60 mg/g) content, as well as the best free radical scavenging properties when compared to other Bangladeshi honey samples [14]. In addition, the presence of a number of phenolic acids including gallic, vanillic, and trans-cinnamic acids and pyrogallol and flavonoid compounds including quercetin, naringin, and rutin has been identified through high performance liquid chromatography (HPLC) analysis [15]. Further insights into its capacity to protect cells from the oxidative stress induced DNA damage uncovered its medicinal importance related to degenerative diseases such as cardiovascular diseases [15]. Epidemiological studies on the cardioprotective effects of flavonoids suggest that dietary intake of flavonoids has the potential to play some preventive role in coronary heart diseases [16], while the underlying cellular mechanism remains unknown. Therefore, the present study was designed to investigate the cardioprotective effects of Sundarban honey to identify the possible therapeutic efficacy on the activities of cardiac troponin I, cardiac marker enzymes, the lipid profile, lipid peroxidation, and antioxidant enzymes in rats with myocardial infarction induced by supramaximal doses of ISO.

2. Materials and Methods

2.1. Experimental Animals

Adult male Wistar rats (170–190 g) were used in this study. Animals were bred and reared in the animal housing facility of the Department of Biochemistry and Molecular Biology, Jahangirnagar University, in a room with a constant temperature of 23 ± 2°C and a humidity ranging between 40% and 70%. The rats were housed in plastic cages with hard-wood-chip bedding under a natural 12 h day-night cycle. The rats were provided with a standard laboratory pellet diet and water ad libitum. The experiments were conducted according to the ethical guidelines approved by the Bangladesh Association for Laboratory Animal Science and the Biosafety, Biosecurity, and Ethical Committee of Jahangirnagar University [Approval number BBEC, JU M (2013.2.a)].

2.2. Drugs and Chemicals

The assay kit used to estimate cardiac troponin I (cTn I) was purchased from JAJ International, Inc., San Diego, USA. Other assay kits for the measurement of creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), aspartate transaminase (AST) and alanine transaminase (ALT), total cholesterol (TC), triglycerides (TGs), and high-density lipoprotein-cholesterol (HDL-C) were all purchased from Stanbio Laboratory, USA. The assay kits for superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GRx) were all purchased from Abnova Corporation, Taiwan. ISO and 1,1,3,3-tetraethoxypropane were purchased from Nacalai Tesque, Inc., Kyoto, Japan. All of the chemicals and reagents used in this study were of analytical grade.

2.3. Honey Sample

The multifloral honey sample was collected from Sundarban, Bangladesh, the largest mangrove forest of the world, in February 2013.

2.4. Induction of Experimental MI

ISO was dissolved in normal saline and was subcutaneously injected into rats (85 mg/kg) at 24 h intervals for 2 days to induce experimental MI. The ISO dose was chosen based on a pilot study for ISO dose fixation and on that used in previous studies [11, 17].

2.5. Experimental Design

After a one-week acclimation period, animals were randomly divided into 4 groups (with 8 rats in each group) and were treated as follows:

 Sham: animals received distilled water (2 mL/kg) for 6 weeks, followed by injection with normal saline (1 mL) on the 43rd and 44th days. SH + sham: animals received only SH (5 g/kg) for 6 weeks, followed by injection with normal saline (1 mL) on the 43rd and 44th days. SH + ISO: animals were orally pretreated with SH (5 g/kg) by gastric gavage needle for 6 weeks, followed by injection with ISO (85 mg/kg) on the 43rd and 44th days. ISO: animals received distilled water (2 mL/kg) for 6 weeks, followed by injection with ISO (85 mg/kg) on the 43rd and 44th days.

During the experimental period, the body weights of the rats were regularly recorded and the doses were administered accordingly. The dose of SH was also selected based on the results of recent studies, in which the treated honey sample (SH) and other honey samples showed strong hepatoprotective effects [2, 18]. Reduced locomotive activities with increased water intake following the first ISO treatment and worsened condition following the administration of the second ISO dose were observed. All rats survived until they were sacrificed. Forty-eight hours after the first dose of ISO, all animals were sacrificed by decapitation. Blood samples (3 mL) were collected, and serum was separated by centrifugation. Immediately following blood collection, the heart samples were separated from the surrounding tissues and washed twice with ice-cold phosphate buffer saline (PBS). The samples were homogenized in phosphate buffer (25 mM, pH 7.4) to make approximately 10% w/v homogenates. The homogenates were then centrifuged at 1700 rpm for 10 min, and the supernatant was collected and stored at −20°C temperature until biochemical analysis. Some of the heart samples were stored in 10% formalin for histopathological examination (Figure 1).

Figure 1: Schematic representation of experimental design of the study.

2.6. Biochemical Analysis of Serum

An enzyme immunoassay kit was used for the determination of cardiac specific troponin I (cTn I) in serum samples using an ELISA microplate reader (Digital and Analog System RS232, Das, Italy). Standard assay kits were used to determine the levels of CK-MB, LDH, AST, ALT, TC, TGs, and HDL-C in serum samples with a PD-303S Spectrophotometer (APEL, Japan). Serum LDL-C levels were calculated based on a formula provided by Friedewald et al. [19]:

2.7. Biochemical Analysis of Heart Tissue

Malondialdehyde (MDA) levels were assayed to detect lipid peroxidation products in heart tissues. MDA, referred to as thiobarbituric acid-reactive substance (TBARS), was measured at 532 nm according to the method of Ohkawa et al. [20], and the levels of TBARS are expressed as nmol of TBARS per mg of protein.

The heart tissue homogenates were recentrifuged at 12,000 rpm for 10 min at 4°C using Eppendorf centrifuge 5415D (Germany). Clean heart tissue supernatants were obtained and used to estimate the activities of endogenous antioxidative enzymes, including superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GRx) using standard assay kits and a microplate reader (Digital and Analog System RS232, Das, Italy). The levels of SOD, GPx, and GRx are expressed as units/mg of protein, nmol of NADPH oxidized/min/mg of protein, and nmol of NADPH oxidized/min/mg of protein, respectively. The total protein in heart tissue homogenates was estimated by the method of Lowry et al. [21].

2.8. Histopathological Examination

After sacrifice, the heart was rapidly dissected out and immediately washed with saline, followed by fixation in 10% formalin. The fixed tissues were embedded in paraffin and cut into serial sections (5 μm thick). Each section was stained with hematoxylin and eosin (H&E). Microscopic observation was performed using a fluorescence microscope with normal spectra (Olympus DP72, Tokyo, Japan). Photomicrographs were taken with a digital camera (Olympus DP72, Tokyo, Japan) attached to the microscope. The pathologist who performed the histopathological evaluation was blinded to the treatment assignments of the different study groups.

2.9. Statistical Analysis

The results of all groups are shown as the mean values ± standard deviation (SD). Data were analyzed using SPSS (Statistical Packages for Social Science, version 20.0, IBM Corporation, New York, USA) and Microsoft Excel 2007 (Redmond, Washington, USA). Statistical analyses of biochemical data were performed by Tukey’s test; was accepted as a statistically significant value.

3. Results

There were no significant differences in the body weights observed between the groups (Table 1). The heart weights were significantly increased in ISO-administered rats compared with sham rats. In rats pretreated with SH prior to ISO treatment, the heart weights were significantly reduced compared with rats treated with ISO alone. No significant difference was observed in rats treated with SH alone compared to the sham group.

Table 1: The effects of SH on the body and heart weights of the rats.

Parameters
Treatment
Percentage change

Sham
SH + sham
SH + ISO
ISO
SH + sham
SH + ISO
ISO

Initial body weight (g)
183.75 ± 9.09
181.22 ± 8.14
187.78 ± 4.69
178.78 ± 3.50
−1.38%
2.19%
−2.70%

Final body weight (g)
219 ± 3.54
206.11 ± 5.44
220.22 ± 8.39
217.83 ± 3.06
−5.89%
0.56%
−0.53%

Body weight gain (g)
31.5 ± 6.36
24.89 ± 2.89
32.67 ± 3.77
32.75 ± 3.79
−20.98%
3.71%
3.96%

Heart weight (g)
0.85 ± 0.01
0.84 ± 0.01
1.07 ± 0.02
1.14 ± 0.01
−1.17%
25.88%
34.12%

Results are expressed as the mean ± SD, . Values in the same row not sharing a common superscript (a, b, and c) differ significantly with each other at . Percentage change is calculated as 100 × [(value of treatment − value of sham)/value of sham].

Figure 2 shows the levels of serum troponin I (cTn I) in normal and ISO-induced rats. Rats treated with ISO showed considerably elevated () serum cTn I levels compared with normal control (sham) rats. ISO-induced rats pretreated with SH daily for a period of 6 weeks showed a significant () decrease in serum cTn I levels compared with rats induced with ISO alone.

Figure 2: The effects of SH on serum cTn I levels. The bars represent the mean ± SD (); bars with different letters are significantly different at .

Figure 3 represents the effects of treatment with SH on the activities of cardiac marker enzymes including CK-MB and LDH AST and ALT in the serum of sham and ISO-induced rats. A marked increase in the activities of serum cardiac enzymes was observed in ISO-induced myocardial-ischemic rats. However, there was a significant () decrease in the activities of CK-MB, LDH, AST, and ALT in rats pretreated with SH before the ISO challenge.

Figure 3: The cardioprotective effects of SH on the activities of cardiac marker enzymes. The bars represent the mean ± SD (); bars with different letters are significantly different at .

The effects of SH treatment on the serum lipid profile (TC, TGs, LDL-C, and HDL-C) of normal and ISO-treated rats are listed in Table 2. Circulating levels of TC, TGs, and LDL-C were significantly () increased in ISO-treated rats, whereas the levels of TC, TGs, and LDL-C were significantly () decreased in the SH + ISO-treated group when compared with the normal control group. A significant () difference was also observed in serum HDL-C levels. Increased levels of HDL-C were found in the SH + sham and SH + ISO-treated groups compared with the sham and ISO-treated groups. Treatment with ISO significantly () reduced the levels of circulating HDL-C.

Table 2: The antihyperlipidemic effects of SH on the serum lipid profiles.

Parameters
Treatment
Percentage change

Sham
SH + sham
SH + ISO
ISO
SH + sham
SH + ISO
ISO

TC (mg/dL)
53.04 ± 2.34
47.54 ± 0.80
57.74 ± 3.13
72.48 ± 2.41
−10.37%
8.86%
36.65%

TGs (mg/dL)
38.13 ± 2.07
29.38 ± 1.09
38.19 ± 3.65
63.04 ± 0.47
−22.95%
0.16%
65.33%

LDL-C (mg/dL)
19.69 ± 1.62
17.43 ± 1.63
20.30 ± 2.72
40.36 ± 1.58
−11.48%
3.09%
104.98%

HDL-C (mg/dL)
24.75 ± 2.15
31.89 ± 0.23
30.78 ± 1.47
19.89 ± 1.21
28.85%
24.36%
−19.63%

Results are expressed as the mean ± SD, . Values in the same row not sharing a common superscript (a, b, and c) differ significantly with each other at . Percentage change is calculated as 100 × [(value of treatment − value of sham)/value of sham].

The effects of the oral administration of SH on LPO levels of rat heart tissues were assessed in the present study as a means to investigate whether SH has any potential to protect cardiac myocytes. Rats injected with ISO showed a significant () increase in the levels of LPO, while prior treatment with SH significantly () altered this parameter. Figure 4 represents the LPO levels of the different experimental group.

Figure 4: The cardioprotective effects of SH on cardiac LPO levels. The bars represent the mean ± SD (); bars with different letters are significantly different at .

The effects of the oral administration of SH on antioxidant enzyme levels in rat heart tissues were assessed in the present study and the results are shown in Table 3.

Table 3: The cardioprotective effects of SH on the activities of superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GRx) in the heart tissues of experimental animals.

Parameters
Treatment
Percentage change

Sham
SH + sham
SH + ISO
ISO
SH + sham
SH + ISO
ISO

SOD (units/mg of protein)
1.71 ± 0.14
1.41 ± 0.00
0.92 ± 0.01
0.02 ± 0.00
−17.54%
−46.19%
−98.83%

GPx (nmol NADPH oxidized/min/mg of protein)
3.18 ± 0.00
2.59 ± 0.73
2.31 ± 0.06
1.02 ± 0.10
−18.55%
−27.36%
−67.92%

GRx (nmol NADPH oxidized/min/mg of protein)
97.91 ± 1.71
99.79 ± 3.83
97.53 ± 0.00
81.69 ± 1.56
1.92%
−0.39%
−16.57%

Results are expressed as the mean ± SD, . Values in the same row not sharing a common superscript (a and b) differ significantly with each other at . Percentage change is calculated as 100 × [(value of treatment − value of sham)/value of sham].

Figure 5 shows histopathological photographs of the heart tissues of experimental rats. Histopathological examination of the myocardial tissue obtained from normal control rats exhibited clear integrity of the myocardial membrane with no observed inflammatory cell infiltration. Histopathological findings confirmed the induction of MI by ISO based on the observation of widespread myocardial structural disorder, coagulative necrosis, the separation of cardiac muscle fibers, and infiltration of inflammatory cells. In rats pretreated with SH, histopathological analysis revealed a decreased degree of inflammatory cell infiltration and relatively well-preserved cardiac muscle fiber morphology. Rats in the baseline group (SH + sham) showed no changes in the histoarchitecture of the heart tissue compared to normal control rats (Table 4).

Table 4: Semiquantitative scoring of the architectural changes evidenced by histopathological examination of rat myocardial tissues.

Parameters
Treatment

Sham
SH + sham
SH + ISO
ISO

Membrane integrity
−
−
−
+++

Separation of muscle fiber
−
−
−
+++

Infiltration of inflammatory cells
−
−
++
+++

Edematous intramuscular space
−
−
+
+++

Scoring was performed as follows: none (−), mild (+), moderate (++), and severe (+++).

(a)

(b)

(c)

(d)

Figure 5: The effects of SH pretreatment on histopathological changes in the heart tissues of experimental rats. (a) Sham group: normal control rat heart showing normal cardiac muscle fibers; (b) SH + sham group: SH pretreated rat heart showing normal muscle fibers without any pathological changes; (c) SH + ISO group: SH pretreated rat myocardial tissues experiencing ISO challenge showing hyperplastic muscle fibers and decreased degree of inflammatory cells; (d) ISO group: only ISO treated rat heart showing cardiac muscle fibers with muscle separation (red arrows), edematous intramuscular space (green arrows), and inflammatory cell infiltration (yellow arrows). Magnification: 40x.

4. Discussion

Our study is the first to report the protective effects of Sundarban honey against MI induced by ISO in rats. In the present study, the heart weights increased significantly with relatively unchanged body weights following ISO administration; this contributed to the increased heart weight to body weight ratio. The increased heart weights might be attributed to increased water content and edematous intramuscular space [22]. However, pretreatment with SH maintained near-normal heart weights.

The level of cTn I has been shown to be a highly sensitive and specific marker of myocardial cell injury. These contractile proteins are not normally found in the serum and are released only after myocardial necrosis [23]. Elevated troponin I levels predict the risk of both cardiac cell death and subsequent infarction [24]. In our study, we observed increased levels of serum cTn I in ISO-treated rats when compared with normal control rats. The observed increase in the levels of cTn I may be due to ISO-induced cardiac damage. Rats challenged with ISO after pretreatment with SH showed significantly decreased cTn I levels when compared with rats treated with ISO alone. It is assumed that SH may preserve the structural and functional integrity of the contractile apparatus, which prevents cardiac damage and leakage of troponins from the heart into the blood.

The myocardium contains high concentrations of diagnostic markers of MI and if metabolically damaged, releases these contents into the extracellular fluids [22]. Of all of the macromolecules that leak from the damaged tissue, enzymes are the best markers of tissue damage because of their tissue specificity and good catalytic activity. When myocardial cells are damaged or destroyed due to a deficient oxygen supply or the presence of high glucose concentrations, the cardiac membrane becomes permeable and may rupture, which results in the leakage of these enzymes [24]. The serum CK-MB activity assay is an important and sensitive diagnostic tool due to the high abundance of this enzyme in the myocardial tissue and its virtual absence in most other tissues. CK-MB isoenzyme activity is a useful early diagnostic index for MI or any type of myocardial injury. Cytosolic enzymes including CK-MB, LDH, AST, and ALT, which serve as diagnostic markers, leak out from the damaged tissue into the blood stream when the cell membrane becomes more permeable or ruptures. The amount of these cellular enzymes in the serum reflects alterations in the plasma membrane integrity and/or permeability [25]. In the present study, rats exposed to ISO showed significant elevations in the levels of all of these marker enzymes in the serum. These results were in line with previous reports and were indicative of ISO-induced necrotic damage to the myocardium and leakiness of the plasma membrane [22, 24, 26]. However, pretreatment with SH resulted in lowered activities of all marker enzyme levels in the serum, demonstrating that SH could contribute to the maintenance of membrane integrity to restrict the leakage of these enzymes. The phenolics such as gallic acid, trans-cinnamic acid, and vanillic acid and flavonoids including quercetin, rutin, and naringin found in SH sample [15] are speculated to confer protection by preserving the membrane integrity [3] and restraining the leakage of these enzymes from the myocardium.

Lipids play an important role in cardiovascular disease, not only by contributing to the development of atherosclerosis but also by modifying the composition, structure, and stability of the cellular membrane. High levels of circulating cholesterol and its accumulation in the heart tissue have been associated with cardiovascular damage [27]. Rats treated with ISO showed a significant increase in the serum levels of TC, TGs, and LDL-C, as previously reported [28]. Generally, the mechanisms of actions of lipolytic hormones including ISO on fat cells are believed to be mediated by the cAMP cascade, in which lipolytic hormones activate adenylate cyclase and thereby increase cAMP formation. Then, cAMP promotes lipolytic activity by activating cAMP-dependent protein kinase, which phosphorylates hormone-sensitive lipase [29] and results in the hydrolysis of stored triacylglycerol, thereby contributing to marked hyperlipidemia [30]. High levels of LDL-C have been positively correlated with MI, while high levels of HDL-C have a negative correlation. HDL-C inhibits the uptake of LDL-C by the arterial walls and facilitates the transport of cholesterol from peripheral tissues to the liver, where it is catabolized and excreted from the body [31]. SH administration significantly restored these alterations, thereby maintaining the normal fluidity and function of the myocardial membrane. The mechanism by which SH increases serum HDL-C and decreases TC, TGs, and LDL-C levels is under investigation. The flavonoids such as rutin have been identified in SH shown to inhibit platelet aggregation, anti-inflammatory effects, antioxidant, and reduction of blood fat and cholesterol level. On the other hand, naringin has also been shown to exhibit cardioprotective effect that might be via its cholesterol lowering and antihyperglycemic activities [32]. Alagwu et al. [33] postulated that honey increases bile cholesterol excretion and lowers plasma cholesterol levels. It is also plausible that honey reduces plasma cholesterol through its antioxidant properties and by enhancing the synthesis of HDL-C in the liver [34]. Polyphenols, particularly gallic acid and catechin, have been reported to inhibit cholesterol esterase [35]. In general, pancreatic cholesterol esterase plays an important role in hydrolyzing dietary cholesterol esters, which liberates free cholesterol in the lumen of the small intestine [36]. Therefore, the inhibition of cholesterol esterase is expected to limit the absorbance of dietary cholesterol, resulting in reduced cholesterol absorption. Moreover, polyphenols can also bind with bile acids to increase their fecal excretion, which has been hypothesized as a possible mechanism for the lowering of plasma cholesterol levels by SH [35].

In recent years, research has increasingly focused on free radicals that may modify biological molecules and result in various pathological conditions [37]. Lipid peroxidation, a type of oxidative deterioration of PUFAs, has been linked with altered membrane structure and inactivation. In our study, ISO treatment resulted in a significant increase in the levels of lipid peroxidation products in the heart tissue. Increased lipid peroxidation appears to be the initial stage in making the tissue more susceptible to oxidative damage. This may be responsible for the observed membrane damage evidenced by elevated lipid peroxidation levels [24]. However, pretreatment with SH showed significantly lowered levels of lipid peroxides in ISO-induced rats. The antioxidant nature of SH may hinder ROS production stimulated by ISO administration and confer the protection to cardiac tissue.

The generation of ROS occurs due to the leakage of electrons from various systems into oxygen. Endogenous antioxidant enzymatic defense is a very important step in the neutralization of oxygen free radical-mediated tissue injury [38]. SOD, catalase, and GPx are the primary free radical scavenging enzymes involved in the first line of cellular defense against oxidative injury, removing O₂ and H₂O₂ before they can interact to form more reactive hydroxyl radicals [39, 40]. In this study, significantly lower SOD and GPx activities were observed in the heart tissues of ISO-induced rats compared with control rats. The observed decrease in the activities of these enzymes may be due to increased generation of ROS including hydrogen peroxide, superoxide, and hydroxyl radicals. This in turn leads to inactivation of these enzymes and results in decreased removal of superoxide radicals, H₂O₂, and highly potent hydroxyl radicals [41, 42]. However, pretreatment with SH improved the scavenging activities of SOD and GPx for superoxide and H₂O₂ produced by ISO. GRx is an antioxidant enzyme involved in the reduction of glutathione disulfide (GSSG) (an end product of the GPx reaction) to glutathione (GSH) [17]. In ISO-treated rats, a marked reduction in GPx activity was observed, leading to reduced availability of the substrate for GRx, thereby decreasing the activity of GRx. However, oral pretreatment of ISO-treated rats with SH restored the activity of GRx, thereby accelerating the conversion of GSSG to GSH. The upregulation of the activity or expression of Nrf2 is plausible; a transcription factor released from its repressor (Keap1) under oxidative or xenobiotic stress [43] is considered as possible mechanism through which SH pretreatment restores antioxidant enzyme functions as also suggested by Erejuwa et al. [44]. The released Nrf2 binds to the antioxidant response element of cytoprotective genes and induces their expression as well as the subsequent expression of free radical scavenging enzymes to neutralize and eliminate the cytotoxic oxidants [43].

The improvements in biochemical parameters reported in the current study were more pronounced than the histopathological results. Nevertheless, histopathological examination of myocardial tissues in normal control rats illustrated clear integrity of the myocardial cell membranes and no inflammatory cell infiltration. Heart tissues from rats treated with ISO alone showed widespread myocardial structure disorder, coagulative necrosis, cardiac muscle fiber separation, and inflammatory cell infiltration. However, the histopathological findings of the SH-pretreated myocardial infracted hearts showed nearly normal morphologic cardiac muscle characteristics and the absence of necrosis compared with hearts from rats treated with ISO alone. The reduced inflammatory cell infiltration and cardiac muscle fiber architectural damage further confirmed the cardioprotective effects of SH.

The findings on cardioprotective efficacy of SH were compared with Malaysian Tualang honey (TH) [41] for the percentage changes in similar biological parameters (Table 5). SH showed better effects compared to TH when MI was induced by ISO at 85 mg/kg body weight.

Table 5: Comparison on percentage change for similar biomarkers between SH and TH pretreatment.

Parameters
Tualang honey treatment
Percentage change (%)

Sham
TH + ISO
ISO
TH
SH

cTn I (ng/mL)
0.06 ± 0.01
0.18 ± 0.05
0.69 ± 0.05
80.38
91.02

CK-MB (U/L)
94.44 ± 3.05
158.03 ± 7.59
242.39 ± 7.30
57.02
60.89

LPO (nmol TBARS/mg of protein)
9.25 ± 0.68
16.84 ± 1.06
22.42 ± 1.09
42.36
91.46

SOD (units/mg of protein)
1.46 ± 0.05
0.19 ± 0.02
0.16 ± 0.01
2.31
53.25

GPx (nmol NADPH oxidized/min/mg of protein)
2.86 ± 0.06
1.86 ± 0.20
1.07 ± 0.19
44.13
59.72

TC
45.55 ± 2.49
56.77 ± 3.70
76.52 ± 4.84
63.77
75.82

TGs
46.31 ± 3.68
53.37 ± 3.91
72.88 ± 3.28
73.41
99.75

Results are expressed as the mean ± SD, . Percentage of protection provided by each honey type is calculated as 100 × [(value of ISO group − value of honey + ISO group)/(value of ISO group − value of sham group)]. TH: Tualang honey and SH: Sundarban honey.

Overall, the probable mechanism by which SH exhibited its protective and ameliorative effects against ISO-induced myocardial damage is via improved antioxidative status and lowered plasma cholesterol level. Further studies should be conducted to clarify the exact mechanism of the cardioprotective effect of SH.

5. Conclusion

Pretreatment with SH significantly altered nearly all biochemical parameters associated with ISO-induced myocardial injury. These findings were confirmed by histopathological examination of normal and infracted rat hearts. This finding may provide scientific support to understand the beneficial effects of SH on cardioprotection against myocardial injury, in which oxidative stress has long been known to contribute to the pathogenesis.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This research is partly supported by the Bangladesh Medical Research Council (BMRC) Grant 2012-2013 and partly by TWAS Research Grant no. 12-237 RG/PHA/AS_C; UNESCO FR: 3240270864 and TWAS Research Grant no. 14-385 RG/PHA/AS_C; UNESCO FR: 3240283438.

References

S. Mustari, “The challenges and coping strategies of ‘mowal’ the honey collectors of sundarban, Bangladesh,” International Research Journal of Social Science, vol. 2, no. 6, pp. 7–11, 2013.

R. Afroz, E. M. Tanvir, Md. F. Hossain et al., “Protective effect of sundarban honey against acetaminophen-induced acute hepatonephrotoxicity in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 143782, 8 pages, 2014.

E. M. Tanvir, R. Afroz, M. A. Z. Chowdhury et al., “Honey has a protective effect against chlorpyrifos-induced toxicity on lipid peroxidation, diagnostic markers and hepatic histoarchitecture,” European Journal of Integrative Medicine, vol. 7, no. 5, pp. 525–533, 2015.

M. Rajadurai and P. Stanely Mainzen Prince, “Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats,” Toxicology, vol. 230, no. 2-3, pp. 178–188, 2007.

P. Anversa and E. H. Sonnenblick, “Ischemic cardiomyopathy: pathophysiologic mechanisms,” Progress in Cardiovascular Diseases, vol. 33, no. 1, pp. 49–70, 1990.

S. Ittagi, V. K. Merugumolu, and R. S. Siddamsetty, “Cardioprotective effect of hydroalcoholic extract of Tecoma stans flowers against isoproterenol induced myocardial infarction in rats,” Asian Pacific Journal of Tropical Disease, vol. 4, no. 1, pp. S378–S384, 2014.

E. R. Petrich, O. Schanne, and A. P. Zumino, “Electrophysiological responses to ischemia and reperfusion,” in Myocardial Ischemia: Mechanisms, Reperfusion, Protection, pp. 115–133, Springer, 1996.

C. J. L. Murray and A. D. Lopez, “Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study,” The Lancet, vol. 349, no. 9064, pp. 1498–1504, 1997.

G. Rona, “Catecholamine cardiotoxicity,” Journal of Molecular and Cellular Cardiology, vol. 17, no. 4, pp. 291–306, 1985.

P. K. Singal, N. Kapur, K. S. Dhillon, R. E. Beamish, and N. S. Dhalla, “Role of free radicals in catecholamine-induced cardiomyopathy,” Canadian Journal of Physiology and Pharmacology, vol. 60, no. 11, pp. 1390–1397, 1982.

M. I. Khalil, I. Ahmmed, R. Ahmed et al., “Amelioration of isoproterenol-induced oxidative damage in rat myocardium by Withania somnifera leaf extract,” BioMed Research International, vol. 2015, Article ID 624159, 10 pages, 2015.

Y. Higuchi, “Changes of lipid peroxides and α-tocopherol in rats with experimentally induced myocardial necrosis,” Acta Medica Okayama, vol. 36, no. 2, pp. 113–124, 1982.

J. G. Topliss, A. M. Clark, E. Ernst et al., “Natural and synthetic substances related to human health (IUPAC technical report),” Pure and Applied Chemistry, vol. 74, no. 10, pp. 1957–1985, 2002.

A. Islam, I. Khalil, N. Islam et al., “Physicochemical and antioxidant properties of Bangladeshi honeys stored for more than one year,” BMC Complementary and Alternative Medicine, vol. 12, no. 1, article 177, 2012.

R. Afroz, E. Tanvir, S. Paul, N. C. Bhoumik, S. H. Gan, and M. I. Khalil, “DNA damage inhibition properties of sundarban honey and its phenolic composition,” Journal of Food Biochemistry, 2015.

M. Nandave, S. Ojha, and D. Arya, “Protective role of flavonoids in cardiovascular diseases,” Natural Product Radiance, vol. 4, pp. 166–176, 2005.

V. S. Panda and S. R. Naik, “Cardioprotective activity of Ginkgo biloba phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation,” Experimental and Toxicologic Pathology, vol. 60, no. 4-5, pp. 397–404, 2008.

E. S. El Denshary, M. A. Al-Gahazali, F. A. Mannaa, H. A. Salem, N. S. Hassan, and M. A. Abdel-Wahhab, “Dietary honey and ginseng protect against carbon tetrachloride-induced hepatonephrotoxicity in rats,” Experimental and Toxicologic Pathology, vol. 64, no. 7-8, pp. 753–760, 2012.

W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972.

H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.

O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951.

A. Upaganlawar, C. Gandhi, and R. Balaraman, “Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats,” Plant Foods for Human Nutrition, vol. 64, no. 1, pp. 75–80, 2009.

E. Antman, J.-P. Bassand, W. Klein et al., “Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction,” Journal of the American College of Cardiology, vol. 36, no. 3, pp. 959–969, 2000.

D. H. Priscilla and P. S. M. Prince, “Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 118–124, 2009.

K. H. Sabeena Farvin, R. Anandan, S. H. S. Kumar, K. S. Shiny, T. V. Sankar, and T. K. Thankappan, “Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats,” Pharmacological Research, vol. 50, no. 3, pp. 231–236, 2004.

V. Patel, A. Upaganlawar, R. Zalawadia, and R. Balaraman, “Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation,” European Journal of Pharmacology, vol. 644, no. 1–3, pp. 160–168, 2010.

A. M. Salter and D. A. White, “Effects of dietary fat on cholesterol metabolism: regulation of plasma LDL concentrations,” Nutrition Research Reviews, vol. 9, pp. 241–257, 1996.

L. Gesquière, N. Loreau, A. Minnich, J. Davignon, and D. Blache, “Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells,” Free Radical Biology and Medicine, vol. 27, no. 1-2, pp. 134–145, 1999.

C. Morimoto, A. Kiyama, K. Kameda, H. Ninomiya, T. Tsujita, and H. Okuda, “Mechanism of the stimulatory action of okadaic acid on lipolysis in rat fat cells,” Journal of Lipid Research, vol. 41, no. 2, pp. 199–204, 2000.

T. Radhiga, C. Rajamanickam, S. Senthil, and K. V. Pugalendi, “Effect of ursolic acid on cardiac marker enzymes, lipid profile and macroscopic enzyme mapping assay in isoproterenol-induced myocardial ischemic rats,” Food and Chemical Toxicology, vol. 50, no. 11, pp. 3971–3977, 2012.

J. E. Buring, G. T. O'Connor, S. Z. Goldhaber et al., “Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction,” Circulation, vol. 85, no. 1, pp. 22–29, 1992.

V. M. R. Papasani, B. Hanumantharayappa, and A. Annapurna, “Cardioprotective effect of naringin against doxorubicin induced cardiomyopathy in rats,” Indo American Journal of Pharmaceutical Research, vol. 4, pp. 2593–2598, 2014.

E. A. Alagwu, R. O. Nneli, J. N. Egwurugwu, and E. E. Osim, “Gastric cytoprotection and honey intake in albino rats,” Nigerian Journal of Physiological Sciences, vol. 26, no. 1, pp. 39–42, 2011.

E. A. Alagwu, J. E. Okwara, R. O. Nneli, and E. E. Osim, “Effect of honey intake on serum cholesterol, triglycerides and lipoprotein levels in albino rats and potential benefits on risks of coronary heart disease,” Nigerian Journal of Physiological Sciences, vol. 26, no. 2, pp. 161–165, 2011.

S. Ngamukote, K. Mäkynen, T. Thilawech, and S. Adisakwattana, “Cholesterol-lowering activity of the major polyphenols in grape seed,” Molecules, vol. 16, no. 6, pp. 5054–5061, 2011.

J. Brodt-Eppley, P. White, S. Jenkins, and D. Y. Hui, “Plasma cholesterol esterase level is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects,” Biochimica et Biophysica Acta, vol. 1272, no. 2, pp. 69–72, 1995.

S. R. J. Maxwell, “Prospects for the use of antioxidant therapies,” Drugs, vol. 49, no. 3, pp. 345–361, 1995.

G. Polidoro, C. Di Ilio, A. Arduini, G. La Rovere, and G. Federici, “Superoxide dismutase, reduced glutathione and TBA-reactive products in erythrocytes of patients with multiple sclerosis,” International Journal of Biochemistry, vol. 16, no. 5, pp. 505–509, 1984.

V. S. Panda and S. R. Naik, “Evaluation of cardioprotective activity of Ginkgo biloba and Ocimum sanctum in rodents,” Alternative Medicine Review, vol. 14, no. 2, pp. 161–171, 2009.

G. Saravanan, P. Ponmurugan, M. Sathiyavathi, S. Vadivukkarasi, and S. Sengottuvelu, “Cardioprotective activity of Amaranthus viridis Linn: effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats,” International Journal of Cardiology, vol. 165, no. 3, pp. 494–498, 2013.

M. I. Khalil, E. M. Tanvir, R. Afroz, S. A. Sulaiman, and S. H. Gan, “Cardioprotective effects of tualang honey: amelioration of cholesterol and cardiac enzymes levels,” BioMed Research International, vol. 2015, Article ID 286051, 8 pages, 2015.

E. Pigeolet, P. Corbisier, A. Houbion et al., “Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals,” Mechanisms of Ageing and Development, vol. 51, no. 3, pp. 283–297, 1990.

M. Kobayashi, L. Li, N. Iwamoto et al., “The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds,” Molecular and Cellular Biology, vol. 29, no. 2, pp. 493–502, 2009.

O. Erejuwa, S. Sulaiman, M. Suhaimi, K. Sirajudeen, S. Salleh, and S. Gurtu, “Impaired Nrf2-ARE pathway contributes to increased oxidative damage in kidney of spontaneously hypertensive rats: Effect of antioxidant (honey),” International Journal of Cardiology, vol. 152, supplement 1, article S45, 2011.